
Sign up to save your podcasts
Or
It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.
4.8
2525 ratings
It is possible to improve and prolong the life of patients with hormone receptor-positive metastatic breast cancer, according to the results of a new phase III clinical trial. Massimo Cristofanilli, MD, principal investigator of the trial explains the results and the state of breast cancer in America today.
9,131 Listeners
91 Listeners
32,283 Listeners
43,483 Listeners
6,670 Listeners
86,708 Listeners
4 Listeners
0 Listeners
32 Listeners
9,593 Listeners
7,928 Listeners
38,676 Listeners
28,304 Listeners
15,237 Listeners
41,435 Listeners
10,556 Listeners
6 Listeners
5,290 Listeners
1,089 Listeners